Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Supplies and Components Index
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • MedTech Resources
    • Medtech Events in 2025
    • The 2024 Medtech Big 100
    • Medical Device Handbook
    • MedTech 100 Index
    • Subscribe to Print Magazine
    • DeviceTalks
    • Digital Editions
    • eBooks
    • Educational Assets
    • Manufacturer Search
    • Podcasts
    • Print Subscription
    • Webinars / Digital Events
    • Whitepapers
    • Voices
    • Views
    • Video
  • 2025 Leadership
    • 2024 Winners
    • 2023 Winners
    • 2022 Winners
    • 2021 Winners
  • Women in Medtech
  • Advertise
  • Subscribe

ImmunGene’s Pipeline of Next Generation Cancer Therapeutics Featured in BioWorld Today

November 11, 2010 By Bio-Medicine.Org

THOUSAND OAKS, Calif., Nov. 11, 2010 /PRNewswire/ — ImmunGene,
Inc., a privately held drug development company focused on targeted
antibody therapeutics with numerous anti-cancer functions built
into a single therapy, announced today that a profile of the
company and its pipeline is featured in the November 21 issue of
BioWorld Today in the NewCo section http://www.bioworld.com/.

The publication noted that, “ImmunGene is currently in advanced
partnership discussion with several biotech and pharma companies
for its payload… The firm’s approach involves fusing a monoclonal
antibody with a cytokine, initially interferon, for local delivery
to the tumor. Called a CmAb, the molecule can be aimed ‘directly
where we want it to go,’ (CEO Sanjay) Khare said.”

The addition of the cytokine means that: “‘…our CmAbs can do
more [than other antibody arming ADCs] since select cytokines are
associated with several desirable anti-tumor functions,’ he said.
CmAbs also are genetically engineered molecules, which could make
them simpler and cheaper to produce. ‘There’s no multistep
manufacturing process,’ Khare added.”

“Another benefit is that the CmAbs can be dosed at a very low
level and still be efficacious. ImmunGene’s researchers, for
example, have been able to limit interferon activity in CmAb to
one-one hundredth of the unfused IFN. By fusing it with an antibody
that binds only to tumor cells, that interferon dose is sufficient
to initiate cell death. ImmunGene’s lead CmAb candidate, IGN002, is
a third-generation antibody-fusion drug designed to target
CD20-positive tumors, initially going after non-Hodgkin’s lymphoma
not treatable by Rituxan (rituximab, Genentech Inc./Roche AG and
Biogen Idec Inc.),” noted the BioWorld article.

Dr. Sanjay Khare, ImmunGene’s Chief Executive Officer said, “We
are pleased to receive recognition from a global biotech
publication for ImmunGene’s pipeline of next genera

‘/>”/>

SOURCE

Related Articles Read More >

An illustration of Embolization Inc.'s Nitinol Enhanced Device (NED).
This nitinol vascular embolization device has another shape memory material up its sleeve
July 2025 edition: The Surgical Robotics issue, featuring Capstan Medical, J&J and Zimmer Biomet
A photo of Capstan Medical's mitral valve implant, which uses nitinol.
Capstan Medical’s R&D head discusses the heart valve and robotics startup’s tech, engineering challenges and solutions, advice for others in medtech and how to join his team
An illustration of a neurosurgeon using a robotic endoscope to remove a brain tumor.
MDO Nitinol Innovation Special Report
“mdo
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest medical device business news, application and technology trends.

DeviceTalks Weekly

See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech100 Index
  • Medical Tubing + Extrusion
  • Medical Design Sourcing
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to our E-Newsletter
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2025 WTWH Media, LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media LLC. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Supplies and Components Index
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • MedTech Resources
    • Medtech Events in 2025
    • The 2024 Medtech Big 100
    • Medical Device Handbook
    • MedTech 100 Index
    • Subscribe to Print Magazine
    • DeviceTalks
    • Digital Editions
    • eBooks
    • Educational Assets
    • Manufacturer Search
    • Podcasts
    • Print Subscription
    • Webinars / Digital Events
    • Whitepapers
    • Voices
    • Views
    • Video
  • 2025 Leadership
    • 2024 Winners
    • 2023 Winners
    • 2022 Winners
    • 2021 Winners
  • Women in Medtech
  • Advertise
  • Subscribe